Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

NCT01817530 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

571

Enrollment

INDUSTRY

Sponsor class

Conditions

Heavy Uterine Bleeding
Uterine Fibroids

Interventions

OTHER: Elagolix placebo
DRUG: Elagolix
DRUG: 0.5 mg estradiol / 0.1 mg norethindrone acetate
DRUG: 1 mg estradiol / 0.5 mg norethindrone acetate
DRUG: E2/NETA placebo

Sponsor

AbbVie